The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer

Author:

Kourie Hampig R1ORCID,Ibnshamsah Fahad2,Zouein Joseph1ORCID,Naim Nabih1ORCID,Abbasi Salah3,Allahloubi Nasr4,Al-Naqqash Manwar5,Alolayan Ashwaq6,Alshehri Ahmed7,Bitar Nizar8,Bounedjar Adda9,Farsi Abdulaziz Al10,Shamsi Humaid El1112,Ghali Ramy13,Jaafar Hassan14,Larbaoui Blaha15,Mahrous Mervat16,Mrabti Hind17ORCID,Nweir Abdul Razzak18,Oukkal Mohamed19,Rasul Kakil20,Razavi Mohsen21,Turfa Rim22,Khatib Sami23,Shamseddine Ali24ORCID

Affiliation:

1. Department of Hematology–Oncology, Faculty of Medicine, Saint Joseph University of Beirut

2. Adult Medical Oncology King Fahad Specialist Hospital Dammam, KSA

3. Al-Khalidi Medical Center, Jordan

4. National Cancer Institute, Cairo University, Egypt

5. College of Medicine, University of Baghdad, Iraq

6. The National Guard Hospital, Riyadh, KSA

7. King Abdulaziz Medical City, Jeddah, KSA

8. Sahel General Hospital, Lebanon

9. Faculty of Medicine, University of Blida 1, Algeria

10. Royal Hospital, Muscat, Oman

11. Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates

12. Emirates Oncology Society, Dubai, United Arab Emirates

13. Department of Clinical Oncology, Ain Shams University, Egypt

14. SKSH, UAE

15. Department of Medical Oncology Anti cancer center ‘Emir Abdel Kader’ Oran, Algeria

16. Prince Sultan Military Medical City, Riyadh, KSA

17. Institut National d'oncologie, Mohamed V University, Rabat, Morocco

18. Hama National Hospital, Ministry of Health, Syria

19. Department of Medical Oncology, Beni Messous University Hospital, Algiers, Algeria

20. NCCCR, Qatar

21. Iran University of Medical Sciences, Iran

22. King Hussein Cancer Center KHCC, Jordan

23. Al Khaldi Hospital, Jordan

24. Hematology–Oncology Division & Naef K Basile Cancer Institute, American University of Beirut, Lebanon

Abstract

Colorectal cancer (CRC) is ranked as the third most prevalent and the second deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, the number of CRC cases increased over the past decades and will nearly double by 2030. The lack of clear MENA guidelines for the management of patients with CRC represents a step backwards in the fight against this burden. Therefore a panel of 24 MENA experts in the field of gastrointestinal oncology developed, using a Delphi process, the first consensus recommendations for the management of patients with advanced CRC. Forty-seven different statements were formulated in the areas of epidemiology, screening, biomarkers and treatment. These recommendations will guide, standardize and unify the management of this cancer in the MENA region.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Reference75 articles.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3